Company news
Cogstate Ltd news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Interim Business Update
December 5, 2017
Cogstate cleared by FDA to start marketing Cognigram in U.S.
July 26, 2017
FY17 Earnings Update
July 10, 2017
Cogstate selected as preferred provider for Lilly
May 17, 2017
Appendix 4D and Half-Year Financial Report
February 22, 2017
Cogstate enters into agreement with Clinical Ink
October 25, 2016
2016 Financial Year Results
August 17, 2016
Chairmans Address to Shareholders
March 30, 2016
JV Agreement Signed
March 30, 2016
CogState 2010 AGM Address
March 30, 2016
NRL mandates use of CogState for concussion management
March 30, 2016
Growth in sales contracts delivers strong Q1 results
March 30, 2016
CogState Tests Used in Successful Ph 2 Schizophrenia Study
March 30, 2016
CogState announces partnership in area of cognitive training
March 30, 2016
CogState Again Used in Successful Schizophrenia Study
March 30, 2016
Business Update - Unaudited Full Year Profit Results
March 30, 2016
CogState signs sales contract for phase 3 study
March 30, 2016
CogState signs sales contract for phase 2 study
March 30, 2016
CogState signs sales contract for large phase 2 study
March 30, 2016
CogState Signs Contract For Phase 2 Schizophrenia Study
March 30, 2016
CogState partners with Merck Canada
March 30, 2016
Merck releases new data on effectiveness of Cognigram
March 30, 2016
Growing recognition of Cogstate test as a cognitive tool
March 30, 2016
CogState launches Cognigram test in Canada
March 30, 2016
Fully Underwritten Non-Renounceable Rights Issue / Placement
March 30, 2016
Business Update and First Half Financial Guidance
March 30, 2016
30 Sep 2013 Business Update and Appendix 4C
March 30, 2016
Precision Recruitment chosen for phase III Alzheimers study
March 30, 2016
Contracts signed since 1 July 2014 hit $9 million
March 30, 2016
Cogstate Test to be used in large paediatric clinical trial
March 30, 2016
Cogstate signs first client to Precision Recruitment
March 30, 2016
Cogstate signs $7.3 million sales contract
March 30, 2016
Cogstate provides update on sales contracts
March 30, 2016
Business update and guidance on FY14 results
March 30, 2016
Cogstate enters into Letter of Intent for sale of Axon Sport
March 30, 2016
Cogstate signs US$2m sales contract
March 17, 2016
Appendix 4C - quarterly (amended)
February 11, 2016
Sales Contract Update
February 10, 2016
Sales contract update
February 10, 2016
Rights Issue Offer Document
February 10, 2016
Quarterly Business Update and Cashflow - 30 June 2013
February 10, 2016
Proposed Issue of Unlisted Options
February 10, 2016
Preliminary Final Report and Annual Report
February 10, 2016
Preliminary Final Report
February 10, 2016
Non-Executive Director Appointment and Private Placement
February 10, 2016
Launch of Axon Sports
February 10, 2016
FY15 Half Year Results Guidance
February 10, 2016
CogState tests helping to detect Alzheimers disease
February 10, 2016
Cogstate Test Provides Better Assessment than Observation
February 10, 2016
Cogstate technology chosen for major Phase III trial
February 10, 2016
Calls
Decks
The 5 newest of 69 decks. Every deck is listed under its year.
- FY2026 Earnings Presentation
Earnings · 20 slides · Aug 18, 2026
- Investor Presentation (February 2026)
Investor deck · 22 slides · Feb 19, 2026
- Barrenjoey Emerging Growth Conference 2025
Conference · 15 slides · Nov 25, 2025
- FY2025 Earnings Presentation
Earnings · 21 slides · Aug 22, 2025
- H1 2025 Earnings Presentation
Earnings · 17 slides · Feb 20, 2025